4.4 Article

Morphological macrovascular alterations in complex regional pain syndrome type I demonstrated by increased intima-media thickness

Journal

BMC NEUROLOGY
Volume 13, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2377-13-14

Keywords

Complex regional pain syndrome; Macrovascular changes; Intima-media thickness; Inflammatory alterations

Funding

  1. Ruhr University Bochum [F634-2008, K046-10]
  2. Sonosite (Nurnberg, Germany)
  3. GE Healthcare (Solingen, Germany)
  4. Esaote (Cologne, Germany)
  5. BK Medical (Pinneberg, Germany)
  6. Pajunk (Geisingen, Germany)
  7. B. Braun (Melsungen, Germany)
  8. German Federal Ministry of Education and Research (BMBF) [01EM0107, 01EM0502]
  9. Pfizer
  10. MSD
  11. Mundipharma
  12. Grunenthal
  13. Astellas
  14. Lilly
  15. Sanofi Aventis
  16. Wyeth
  17. Eli Lilly

Ask authors/readers for more resources

Background: Although intima-media thickness (IMT) was increased in several inflammatory diseases, studies investigating whether the inflammatory processes lead to macrovascular alteration with increased IMT in complex regional pain syndrome (CRPS) lack. Methods: Using ultrasound (high-resolution B-mode), we compared bilaterally the IMT of the common carotid artery (CCA-IMT), the radial artery (RA-IMT), the brachial artery (BRA-IMT) and the quotient Q(RA/CCA), in CRPS type I (n=17), peripheral nerve injury (PNI, n=17) and pain-free controls (PFC, n=22, matched to CRPS by gender, age and traditional cardiovascular risk factors). Statistics: Spearman's correlation, paired t-test, ANOVA (p<0.05). Results: Compared to PFC, RA-IMT were significantly increased in both patient groups bilaterally (mean +/- standard deviation, CRPS affected side vs. PFC dominant side: 0.32 +/- 0.08 mm vs. 0.19 +/- 0.08 mm, p<0.001; PNI affected side vs. PFC dominant side: 0.27 +/- 0.09 mm vs. 0.19 +/- 0.08 mm, p<0.05; CRPS non-affected side vs. PFC non-dominant side: 0.30 +/- 0.10 mm vs. 0.19 +/- 0.09 mm, p<0.001; PNI non-affected side vs. PFC non-dominant side: 0.25 +/- 0.10 mm vs. 0.19 +/- 0.09 mm, p<0.05) and Q(RA/CCA) (CRPS affected-side vs. PFC dominant side: 0.49 +/- 0.12 vs. 0.30 +/- 0.11, p<0.001; PNI affected side vs. PFC dominant side: 0.41 +/- 0.10 vs. 0.30 +/- 0.11, p<0.05; CRPS non-affected side vs. PFC non-dominant side: 0.43 +/- 0.19 vs. 0.30 +/- 0.13, p<0.001; PNI non-affected side vs. PFC non-dominant side: 0.39 +/- 0.14 vs. 0.30 +/- 0.13, p<0.05), and BRA-IMT - only on the affected side in CRPS (CRPS: 0.42 +/- 0.06 mm vs. PFC: 0.35 +/- 0.08 mm; p<0.05). In CRPS, Q(RA/CCA) was significantly higher on the affected side compared to PNI (p<0.05). However, only CRPS displayed within-group side-to-side differences with a significantly increased RA-IMT and Q(RA/CCA) on the affected side (p<0.05). The CCA-IMT was comparable between all groups and sides. Conclusions: The increased IMT of peripheral arteries in CRPS suggests ongoing inflammatory process. Until now, only endothelial dysfunction has been reported. The presented morphological macrovascular alterations might explain the treatment resistance of some CRPS patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available